Skip to main navigation Skip to main content
  • KSCN
  • E-Submission

CNR : Clinical Nutrition Research

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

3
results for

"Mohammad Hassan Javanbakht"

Article category

Keywords

Publication year

Authors

"Mohammad Hassan Javanbakht"

Original Articles
[English]
The Association Between Dietary Diversity Score and Cardiovascular Risk Factors Among Patients With Pemphigus Vulgaris: A Cross Sectional Study
Atefeh Seifollahi, Mahboubeh Rezaei Fazl, Leila Setayesh, Mohammad Hassan Javanbakht, Maryam Daneshpazhooh, Sakineh Shab-Bidar, Mehdi Yaseri
Clin Nutr Res 2022;11(4):289-301.   Published online October 24, 2022
DOI: https://doi.org/10.7762/cnr.2022.11.4.289

This study was conducted to evaluate the associations between dietary diversity score (DDS) and cardiovascular risk factors in this population. In this cross-sectional study, 187 patients, aged 18–65 years with pemphigus vulgaris were included. DDS was assessed by a 24-hour dietary recall method. Anthropometric measures and biochemical parameters assessed according to standard protocols. Multivariate linear regression analyses used for detecting any associations between DDS and cardiovascular risk factors. The mean ± standard deviation age and body mass index of studied participants were (46.71 ± 11.49 years) and (27.83 ± 4.39 kg/m2) respectively. Our findings showed that a higher DDS intake was related with higher consumption of vegetables (p = 0.001), dairy products (p < 0.001), cereals (p = 0.002), red and processed meat (p < 0.001), sweets and desserts (p < 0.001). After controlling for confounding variables, the results showed positive associations between DDS and high-density lipoprotein cholesterol (HDL-C, β = 1.87, 95% confidence interval [CI], 0.30–3.45, p = 0.02) and total cholesterol (TC) levels (β = 6.41, 95% CI, 1.62–11.03, p = 0.02) (β = 1.75, 95% CI, 0.20–3.30, p = 0.02). However, there were no associations between DDS and prevalence of obesity and glucose homeostasis. The results of this cross-sectional study showed that DDS might be associated with increased HDL-C and TC. However, further prospective studies are needed to prove these findings.

Citations

Citations to this article as recorded by  
  • Dietary diversity and the risk of metabolic syndrome in a Japanese population: an analysis of baseline cross-sectional data from the J-MICC study
    Zin Wai Htay, Nobuaki Michihata, Yohko Nakamura, Yoshitaka Hippo, Jun Otonari, Hiroaki Ikezaki, Yuichiro Nishida, Chisato Shimanoe, Takashi Tamura, Mako Nagayoshi, Yasufumi Kato, Yudai Tamada, Asahi Hishida, Shiroh Tanoue, Daisaku Nishimoto, Teruhide Koya
    European Journal of Clinical Nutrition.2025; 79(11): 1106.     CrossRef
  • Association of dietary diversity score and severity of pemphigus vulgaris: a cross-sectional study
    Banafsheh Jafari Azad, Maryam Fallah, Zahra Esmaeily, Anahita Najafi, Kamran Balighi, Maryam Daneshpazhooh, Soraiya Ebrahimpour-Koujan
    BMC Nutrition.2025;[Epub]     CrossRef
  • The Past, Present, Future: Pathophysiology, Diagnosis, and Treatment of Human Skin Diseases
    Niki Ebrahimnejad, Duaa Jaafar, Heidi Goodarzi
    Physiologia.2024; 4(1): 81.     CrossRef
  • Associations between dietary diversity and dyslipidemia among Japanese workers: cross-sectional study and longitudinal study findings
    Thi Thuy Bui, Mariko Nakamoto, Kana Yamada, Akiko Nakamoto, Akiko Hata, Nanako Aki, Yosuke Shikama, Yukiko Bando, Takako Ichihara, Takako Minagawa, Ayako Tamura, Yumi Kuwamura, Makoto Funaki, Tohru Sakai
    European Journal of Nutrition.2024; 63(6): 2109.     CrossRef
  • The Role of Nutrition in the Pathogenesis and Treatment of Autoimmune Bullous Diseases—A Narrative Review
    Aleksandra Kajdas, Agnieszka Żebrowska, Anna Zalewska-Janowska, Aneta Czerwonogrodzka-Senczyna
    Nutrients.2024; 16(22): 3961.     CrossRef
  • 9 View
  • 0 Download
  • 5 Crossref
[English]
Effect of Eicosapentaenoic Acid Supplementation on Paraoxonase 2 Gene Expression in Patients with Type 2 Diabetes Mellitus: a Randomized Double-blind Clinical Trial
Mohammad Hassan Golzari, Mohammad Hassan Javanbakht, Ehsan Ghaedi, Hamed Mohammadi, Mahmoud Djalali
Clin Nutr Res 2019;8(1):17-27.   Published online January 28, 2019
DOI: https://doi.org/10.7762/cnr.2019.8.1.17

Type 2 diabetes mellitus (T2DM) is recognized as one of the most prevalent metabolic diseases, and it is mostly associated with oxidative stress, atherosclerosis and dyslipidemia. Paraoxonase 2 (PON2) due to its antioxidant properties may play a role in the atherosclerosis development. Although long-chain omega-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) have been shown to reduce the risk of cardiovascular disease, the exact mechanism of action is still unknown. Our goal in this study was to determine the effect of EPA administration on gene expression of PON2 in patients with T2DM. Present study was a randomized, controlled double-blind trial. Thirty-six patients with T2DM were randomly allocated to receive 2 g/day EPA (n = 18) or placebo (n = 18) for 8 weeks. There were no significant differences between 2 groups concerning demographic or biochemical variables, and dietary intakes as well (p > 0.05). However, patients received EPA showed a significant increase in the gene expression of PON2 compared with placebo group (p = 0.027). In addition, high-density lipoprotein cholesterol increased and fasting blood sugar decreased significantly after EPA supplementation compared with control group. Taken together, supplementation with 2 g/day EPA could be atheroprotective via the upregulation of PON2 in patients with T2DM.

Trial Registration

ClinicalTrials.gov Identifier: NCT03258840

Citations

Citations to this article as recorded by  
  • Comparison of the efficacy of fish oil and probiotic supplementation on glucose and lipid metabolism in patients with type 2 diabetes: a systematic review and network meta-analysis
    Mei Zhang, Fan Yang, Qiu Feng, Yanghong Ou, Jiaxing Zhang, Haiyan Wan, Hongyi Cao, Peng Ning
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements
    Michael Miller, Lale Tokgozoglu, Klaus G. Parhofer, Yehuda Handelsman, Lawrence A. Leiter, Ulf Landmesser, Eliot A. Brinton, Alberico L. Catapano
    Expert Review of Cardiovascular Therapy.2022; 20(8): 609.     CrossRef
  • The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis
    Yanan Xiao, Qifang Zhang, Xueling Liao, Ulf Elbelt, Karsten H. Weylandt
    Prostaglandins, Leukotrienes and Essential Fatty Acids.2022; 182: 102456.     CrossRef
  • Insights into the role of paraoxonase 2 in human pathophysiology
    Fauzia Parween, Rinkoo Devi Gupta
    Journal of Biosciences.2022;[Epub]     CrossRef
  • Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
    M. John Chapman, Jose L. Zamorano, Klaus G. Parhofer
    Pharmacology & Therapeutics.2022; 237: 108172.     CrossRef
  • EPA’s pleiotropic mechanisms of action: a narrative review
    John R. Nelson, Matthew J. Budoff, Omar R. Wani, Viet Le, Dhiren K. Patel, Ashley Nelson, Richard L. Nemiroff
    Postgraduate Medicine.2021; 133(6): 651.     CrossRef
  • The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention
    Kamini Trivedi, Viet Le, John R. Nelson
    Postgraduate Medicine.2021; 133(1): 28.     CrossRef
  • Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies
    Brian Olshansky, Mina K Chung, Matthew J Budoff, Sephy Philip, Lixia Jiao, Ralph T Doyle, Jr., Christina Copland, Alex Giaquinto, Rebecca A Juliano, Deepak L Bhatt
    European Heart Journal Supplements.2020; 22(Supplement): J34.     CrossRef
  • Improvement of NRF2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: A double-blind randomised placebo-controlled clinical trial
    Pegah Golpour, Mitra Nourbakhsh, Maryam Mazaherioun, Leila Janani, Mona Nourbakhsh, Parichehreh Yaghmaei
    Diabetes Research and Clinical Practice.2020; 162: 108120.     CrossRef
  • Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview
    Débora Levy, Cadiele Oliana Reichert, Sérgio Paulo Bydlowski
    Antioxidants.2019; 8(5): 118.     CrossRef
  • Purslane and Garden Cress Seeds as Source of Unconventional Edible Oils for Prevention of Hyperlipidemia
    Doha Abdou Mohamed, Hend Abass Essa, Rasha Salah Mohamed
    Pakistan Journal of Biological Sciences.2019; 22(11): 537.     CrossRef
  • 8 View
  • 0 Download
  • 11 Crossref
[English]
Erythrocyte Membrane Unsaturated (Mono and Poly) Fatty Acids Profile in Newly Diagnosed Basal Cell Carcinoma Patients
Fatemeh Rahrovani, Mohammad Hassan Javanbakht, Ehsan Ghaedi, Hamed Mohammadi, Amir-Hooshang Ehsani, Ali Esrafili, Mahmoud Djalali
Clin Nutr Res 2018;7(1):21-30.   Published online January 24, 2018
DOI: https://doi.org/10.7762/cnr.2018.7.1.21

Studies have reported different changes in the fatty acid composition of red blood cell (RBC) total lipids in patients with various types of cancer. It has been indicated that n-3/n-6 ratio plays a key role in the general consequence of skin photocarcinogenesis. However, to our knowledge there was no study examining the unsaturated fatty acid profile in basal cell carcinoma (BCC) patients. So, we explore the fatty acid composition of RBCs in newly diagnosed BCC patients in a hospital-based case-control study. This study has been conducted on new case BCC patients in Razi Hospital, Tehran, Iran. Fatty acid concentration in erythrocyte membranes defined as relative values after extraction, purification and preparation, by gas chromatography.Analysis revealed that heptadecenoic acid (p = 0.010) and oleic acid (p < 0.001) was significantly higher in BCC patients in comparison with control group. Among polyunsaturated fatty acids (PUFAs), linoleic acid (LA), and arachidonic acid (AA) were significantly higher in BCC patients (p < 0.001). It has been indicated that n-3 was significantly lower (p = 0.040) and n-6 was significantly higher (p = 0.002) in BCC patients. In addition, total PUFA (p < 0.001) and n-6 PUFAs/n-3 PUFAs (p = 0.002) were significantly higher in BCC patients compared to the control group. Here we indicated that new case BCC patient had significantly higher n-6 PUFA and lower n-3 along with other differences in unsaturated fatty acid in comparison with healthy subjects. Our study provides evidence that lipids are important in BCC development.

Citations

Citations to this article as recorded by  
  • Fatty Acids and Membrane Lipidomics in Oncology: A Cross-Road of Nutritional, Signaling and Metabolic Pathways
    Carla Ferreri, Anna Sansone, Rosaria Ferreri, Javier Amézaga, Itziar Tueros
    Metabolites.2020; 10(9): 345.     CrossRef
  • 8 View
  • 0 Download
  • 1 Crossref